Sign in

CIK 0001842295

  • Non-accelerated filer
  • Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-850-5070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,785,701
in 13 filings, $4.6M under 10b5-1 plans

Net −$5,785,701. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-02 Coloma Jason V Chief Executive Officer Sale 10b5-1 −2,257 $30.12 $68K 13,301
2026-11-02 Coloma Jason V Chief Executive Officer Sale 10b5-1 −336 $30.91 $10K 12,965
2026-11-02 Coloma Jason V Chief Executive Officer Sale 10b5-1 −26,563 $30.10 $799K 164,884
2026-11-02 Coloma Jason V Chief Executive Officer Sale 10b5-1 −5,345 $31.05 $166K 186,901
2026-10-29 Dandekar Atul CSBO Exercise or conversion 10b5-1 +6,643 $10.42 $69K 38,959
2026-10-29 Dandekar Atul CSBO Exercise or conversion 10b5-1 +857 $10.42 $9K 39,816
2026-10-29 Dandekar Atul CSBO Sale 10b5-1 −7,500 $32.07 $241K 32,316
2026-10-29 Dandekar Atul CSBO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −6,643 0
2026-10-29 Dandekar Atul CSBO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −857 25,073
2026-10-01 Bernstein Harold President, R&D & CMO Exercise or conversion 10b5-1 +16,141 $10.42 $168K 16,141
2026-10-01 Bernstein Harold President, R&D & CMO Sale 10b5-1 −16,141 $26.93 $435K 0
2026-10-01 Bernstein Harold President, R&D & CMO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −16,141 144,521
2026-10-01 Coloma Jason V Chief Executive Officer Sale 10b5-1 −2,593 $27.02 $70K 15,558
2026-10-01 Coloma Jason V Chief Executive Officer Sale 10b5-1 −31,908 $27.02 $862K 191,447
2026-09-29 Dandekar Atul CSBO Exercise or conversion 10b5-1 +7,500 $10.42 $78K 39,816
2026-09-29 Dandekar Atul CSBO Sale 10b5-1 −7,500 $27.06 $203K 32,316
2026-09-29 Dandekar Atul CSBO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −7,500 6,643
2026-09-04 Bernstein Harold President, R&D & CMO Sale 10b5-1 −9,705 $26.22 $255K 0
2026-09-03 Bernstein Harold President, R&D & CMO Sale −5,130 $26.01 $133K 9,764
2026-09-03 Bernstein Harold President, R&D & CMO Sale −59 $25.78 $2K 9,705

Page 1 of 14 · 267 trades